| Diagnostic yield as an important metric for the evaluation of novel tuberculosis tests: rationale and guidance for future research T Broger, FM Marx, G Theron, BJ Marais, MP Nicol, AD Kerkhoff, ... The Lancet Global Health 12 (7), e1184-e1191, 2024 | | 2024 |
| Enhanced tuberculosis diagnosis with computer-aided chest X-ray and urine LAM in adults with HIV admitted to hospital (CASTLE study): A cluster randomised trial RM Burke, SK Nyirenda, T Mtenga, HH Twabi, E Joekes, NF Walker, ... Clinical Infectious Diseases, ciae273, 2024 | | 2024 |
| Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised … SN Faust, R Haynes, CE Jones, N Staplin, E Whittaker, T Jaki, E Juszczak, ... The Lancet Child & Adolescent Health 8 (3), 190-200, 2024 | 6 | 2024 |
| Evaluation of the Xpert MTB Host Response assay for the triage of patients with presumed pulmonary tuberculosis: a prospective diagnostic accuracy study in Viet Nam, India, the … A Gupta-Wright, H Ha, S Abdulgadar, R Crowder, J Emmanuel, ... The Lancet Global Health 12 (2), e226-e234, 2024 | 3 | 2024 |
| Blazing the trail for innovative tuberculosis diagnostics S Yerlikaya, T Broger, C Isaacs, D Bell, L Holtgrewe, A Gupta-Wright, ... Infection 52 (1), 29-42, 2024 | 3 | 2024 |
| Tuberculosis treatment monitoring tests during routine practice: study design guidance ELH MacLean, AJ Zimmer, S den Boon, A Gupta-Wright, DM Cirillo, ... Clinical Microbiology and Infection, 2024 | 2 | 2024 |
| Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet Diabetes & Endocrinology 11 (12), 905-914, 2023 | 12 | 2023 |
| Target product profiles: tests for tuberculosis treatment monitoring and optimization A Gupta-Wright, S Den Boon, EL MacLean, D Cirillo, F Cobelens, ... Bulletin of the World Health Organization 101 (11), 730, 2023 | 4 | 2023 |
| Perfiles de productos objetivo: pruebas para el seguimiento y la optimización del tratamiento de la tuberculosis A Gupta-Wright, S den Boon, EL Maclean, D Cirillo, F Cobelens, ... Bulletin of the World Health Organization 101 (11), 730-737, 2023 | | 2023 |
| Diagnostic yield of urine lipoarabinomannan and sputum tuberculosis tests in people living with HIV: a systematic review and meta-analysis of individual participant data T Broger, L Koeppel, H Huerga, P Miller, A Gupta-Wright, FX Blanc, ... The Lancet Global Health 11 (6), e903-e916, 2023 | 20 | 2023 |
| Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open … O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 401 (10387), 1499-1507, 2023 | 19 | 2023 |
| Lots of considerations when evaluating the FujiLAM assay–Author's reply H Huerga, A Gupta-Wright, W Muyindike, C Hewison, M Casenghi, ... The Lancet Global Health 11 (4), e502, 2023 | | 2023 |
| Interventions to reduce deaths in people living with HIV admitted to hospital in low-and middle-income countries: a systematic review RM Burke, HH Twabi, C Johnston, M Nliwasa, A Gupta-Wright, K Fielding, ... PLOS global public health 3 (2), e0001557, 2023 | 5 | 2023 |
| Novel FujiLAM assay to detect tuberculosis in HIV-positive ambulatory patients in four African countries: a diagnostic accuracy study H Huerga, M Bastard, AV Lubega, M Akinyi, NT Antabak, L Ohler, ... The Lancet Global Health 11 (1), e126-e135, 2023 | 23 | 2023 |
| Enhanced tuberculosis screening using computer-aided X-ray diagnosis and novel point of care urine lipoarabinomannan assay among adults with HIV admitted to hospital (CASTLE … R Burke, S Nyirenda, H Twabi, M Nliwasa, E Joekes, N Walker, ... JOURNAL OF THE INTERNATIONAL AIDS SOCIETY 25, 216-216, 2022 | | 2022 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 227 | 2022 |
| Tuberculosis diagnostics to reduce HIV-associated mortality: Barnett Christie Lecture 2020 A Gupta-Wright Clinical Infection in Practice 15, 100152, 2022 | | 2022 |
| Diagnostic accuracy of WHO screening criteria to guide lateral-flow lipoarabinomannan testing among HIV-positive inpatients: A systematic review and individual participant data … A Dhana, Y Hamada, AP Kengne, AD Kerkhoff, T Broger, CM Denkinger, ... Journal of Infection 85 (1), 40-48, 2022 | 7 | 2022 |
| Systems and methods for accurate voltage impact on integrated timing simulation JM Geada, NL Rethman, A Gupta US Patent 11,354,475, 2022 | | 2022 |
| Urine tuberculosis diagnostics in patients with advanced HIV J Nel, A Gupta-Wright AIDS 36 (6), 897-898, 2022 | | 2022 |
